Literature DB >> 7317688

Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.

S Arbilla, L A Kamal, S Z Langer.   

Abstract

1 The spontaneous and potassium-evoked release of tritium from the rat substantia nigra prelabelled with [(3)H]-gamma-aminobutyric acid [(3)H]-GABA were assessed in vitro under conditions of superfusion.2 Kainic acid lesions performed in the right caudate nucleus resulted in a 70% reduction in the ability of the homolateral nigral cells to take up and retain [(3)H]-GABA when compared with the unlesioned side. The potassium-evoked release of [(3)H]-GABA remained proportional to the radioactivity retained in the tissue suggesting that the nigral GABA neurones that survived kainic acid treatment were still functional.3 The spontaneous outflow of [(3)H]-GABA was significantly increased by exposure to different concentrations of exogenous GABA (10 to 1000 muM) when amino-oxyacetic acid was present in the incubation medium.4 Apomorphine in concentrations ranging from 1 to 30 muM inhibited the calcium-dependent release of [(3)H]-GABA induced by 1 min exposure to 30 mM K(+). These concentrations of apomorphine did not affect the spontaneous outflow of radioactivity. In vivo administration of haloperidol 0.2 mg/kg antagonized the in vitro inhibition by apomorphine of the K(+)-evoked release of [(3)H]-GABA.5 The results obtained with apomorphine and haloperidol suggest the presence of presynaptic dopamine-like inhibitory receptors in gabaergic nerve terminals.6 Dopamine in concentrations ranging up to 300 muM did not modify either the spontaneous or the K(+)-evoked release of [(3)H]-GABA from the substantia nigra. These concentrations of dopamine effectively displaced [(3)H]-dopamine recently taken up into the substantia nigra.7 Our results do not support the view that dendritic release of dopamine from the substantia nigra might be involved in the physiological modulation of the spontaneous or the stimulation-evoked release of GABA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317688      PMCID: PMC2071740          DOI: 10.1111/j.1476-5381.1981.tb09983.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Synaptic mechanisms in the substantia nigra.

Authors:  A Dray; D W Straughan
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  Dopamine-sensitive adenylate cyclase: location in substantia nigra.

Authors:  K Gale; A Guidotti; E Costa
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

3.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.

Authors:  P Seeman; T Lee
Journal:  Science       Date:  1975-06-20       Impact factor: 47.728

4.  Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites.

Authors:  J W Kebabian; J M Saavedra
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

5.  Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase.

Authors:  O T Phillipson; A S Horn
Journal:  Nature       Date:  1976-06-03       Impact factor: 49.962

6.  On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies.

Authors:  T Hattori; P L McGeer; H C Fibiger; E G McGeer
Journal:  Brain Res       Date:  1973-05-17       Impact factor: 3.252

7.  Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices.

Authors:  L O Farnebo; B Hamberger
Journal:  Acta Physiol Scand Suppl       Date:  1971

8.  Role of -aminobutyric acid (GABA) in the extrapyramidal motor system. 1. Regional distribution of GABA in rabbit, rat, guinea pig and baboon CNS.

Authors:  Y Okada; C Nitsch-Hassler; J S Kim; I J Bak; R Hassler
Journal:  Exp Brain Res       Date:  1971-11-30       Impact factor: 1.972

9.  Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine.

Authors:  J P Long; S Heintz; J G Cannon; J Kim
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

10.  Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies.

Authors:  G K Aghajanian; B S Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

View more
  4 in total

1.  Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action.

Authors:  Mauro Federici; Silvia Natoli; Giorgio Bernardi; Nicola B Mercuri
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

2.  Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata.

Authors:  T Miyazaki; M G Lacey
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

3.  Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raphé nuclei.

Authors:  T P Blackburn; B Cox; T F Lee
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3H]-serotonin from the rat substantia nigra.

Authors:  S Benkirane; S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.